Corporate GovernanceApr 30, 2026, 04:06 PM
CALC Amends 10-K to Detail Executive Comp & Governance
AI Summary
CalciMedica, Inc. filed an Amendment No. 1 on Form 10-K/A to its Annual Report for the fiscal year ended December 31, 2025. This amendment provides the previously omitted information required by Part III of the original filing, covering directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and principal accounting fees. The filing includes detailed compensation tables for named executive officers for 2025 and 2024, as well as information on equity awards and severance policies.
Key Highlights
- CALC filed Form 10-K/A to amend its 2025 Annual Report, adding Part III information.
- CEO A. Rachel Leheny's total compensation for 2025 was $895,410.
- CMO Sudarshan Hebbar's total compensation for 2025 was $763,315.
- CBO Eric W. Roberts' total compensation for 2025 was $703,558.
- The Board of Directors consists of seven members across Class I, II, and III.
- Audit Committee includes Allan Shaw (Chair), Fred Middleton, and Alan Glicklich.
- Company adopted an Insider Trading Policy prohibiting hedging and pledging of securities.
- Severance policies are in place for named executive officers upon certain terminations.
Price Impact
More from CALC